157 related articles for article (PubMed ID: 37679223)
21. Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide.
Voutsas IF; Anastasopoulou EA; Tzonis P; Papamichail M; Perez SA; Baxevanis CN
J Immunother Cancer; 2016; 4():75. PubMed ID: 27891225
[TBL] [Abstract][Full Text] [Related]
22. Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.
Bioley G; Jandus C; Tuyaerts S; Rimoldi D; Kwok WW; Speiser DE; Tiercy JM; Thielemans K; Cerottini JC; Romero P
J Immunol; 2006 Nov; 177(10):6769-79. PubMed ID: 17082590
[TBL] [Abstract][Full Text] [Related]
23. Landscape and selection of vaccine epitopes in SARS-CoV-2.
Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
[TBL] [Abstract][Full Text] [Related]
24. Mutational Analysis of Gene Fusions Predicts Novel MHC Class I-Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer.
Kalina JL; Neilson DS; Lin YY; Hamilton PT; Comber AP; Loy EMH; Sahinalp SC; Collins CC; Hach F; Lum JJ
Clin Cancer Res; 2017 Dec; 23(24):7596-7607. PubMed ID: 28954787
[No Abstract] [Full Text] [Related]
25. The Cancer Epitope Database and Analysis Resource (CEDAR).
Koşaloğlu-Yalçın Z; Blazeska N; Vita R; Carter H; Nielsen M; Schoenberger S; Sette A; Peters B
Nucleic Acids Res; 2023 Jan; 51(D1):D845-D852. PubMed ID: 36250634
[TBL] [Abstract][Full Text] [Related]
26. Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens.
Novak EJ; Liu AW; Gebe JA; Falk BA; Nepom GT; Koelle DM; Kwok WW
J Immunol; 2001 Jun; 166(11):6665-70. PubMed ID: 11359821
[TBL] [Abstract][Full Text] [Related]
27. Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells.
Oh S; Terabe M; Pendleton CD; Bhattacharyya A; Bera TK; Epel M; Reiter Y; Phillips J; Linehan WM; Kasten-Sportes C; Pastan I; Berzofsky JA
Cancer Res; 2004 Apr; 64(7):2610-8. PubMed ID: 15059918
[TBL] [Abstract][Full Text] [Related]
28. Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3.
Consogno G; Manici S; Facchinetti V; Bachi A; Hammer J; Conti-Fine BM; Rugarli C; Traversari C; Protti MP
Blood; 2003 Feb; 101(3):1038-44. PubMed ID: 12393675
[TBL] [Abstract][Full Text] [Related]
29. CD4 and CD8 T-lymphocyte recognition of prostate specific antigen in granulomatous prostatitis.
Klyushnenkova EN; Ponniah S; Rodriguez A; Kodak J; Mann DL; Langerman A; Nishimura MI; Alexander RB
J Immunother; 2004; 27(2):136-46. PubMed ID: 14770085
[TBL] [Abstract][Full Text] [Related]
30. Recognition of prostate and breast tumor cells by helper T lymphocytes specific for a prostate and breast tumor-associated antigen, TARP.
Kobayashi H; Nagato T; Oikawa K; Sato K; Kimura S; Aoki N; Omiya R; Tateno M; Celis E
Clin Cancer Res; 2005 May; 11(10):3869-78. PubMed ID: 15897588
[TBL] [Abstract][Full Text] [Related]
31. Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells.
Schroers R; Huang XF; Hammer J; Zhang J; Chen SY
Cancer Res; 2002 May; 62(9):2600-5. PubMed ID: 11980655
[TBL] [Abstract][Full Text] [Related]
32. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.
Steinitz KN; van Helden PM; Binder B; Wraith DC; Unterthurner S; Hermann C; Schuster M; Ahmad RU; Weiller M; Lubich C; de la Rosa M; Schwarz HP; Reipert BM
Blood; 2012 Apr; 119(17):4073-82. PubMed ID: 22394599
[TBL] [Abstract][Full Text] [Related]
33. Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells.
Smith HA; McNeel DG
J Immunother; 2011 Oct; 34(8):569-80. PubMed ID: 21904219
[TBL] [Abstract][Full Text] [Related]
34. Epitope distribution in ordered and disordered protein regions. Part B - Ordered regions and disordered binding sites are targets of T- and B-cell immunity.
Pavlović MD; Jandrlić DR; Mitić NS
J Immunol Methods; 2014 May; 407():90-107. PubMed ID: 24726865
[TBL] [Abstract][Full Text] [Related]
35. Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes.
Wieckowski E; Chatta GS; Mailliard RM; Gooding W; Palucka K; Banchereau J; Kalinski P
Prostate; 2011 Feb; 71(2):125-33. PubMed ID: 20717900
[TBL] [Abstract][Full Text] [Related]
36. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
Papassavas AC; Barnardo MC; Bunce M; Welsh KI
Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447
[TBL] [Abstract][Full Text] [Related]
37. Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy.
Mitić NS; Pavlović MD; Jandrlić DR
J Immunol Methods; 2014 Apr; 406():83-103. PubMed ID: 24614036
[TBL] [Abstract][Full Text] [Related]
38. Idiotope-Driven T-Cell/B-Cell Collaboration-Based T-Cell Epitope Prediction Using B-Cell Receptor Repertoire Sequences in Infectious Diseases.
Nakamura Y; Moi ML; Shiina T; Shin-I T; Suzuki R
Viruses; 2023 May; 15(5):. PubMed ID: 37243272
[TBL] [Abstract][Full Text] [Related]
39. Novel immunodominant epitopes derived from MAGE-A3 and its significance in serological diagnosis of gastric cancer.
Shen X; Jin J; Ding Y; Wang P; Wang A; Xiao D; Xue X; Zhu S; Zhang L; Zhu G
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1529-38. PubMed ID: 23842851
[TBL] [Abstract][Full Text] [Related]
40. Definition of permissible and immunogenic HLA antigens based on epitope analysis of the HLA specific antibodies produced in sensitized patients.
Papassavas AC; Stavropoulos-Giokas C; Boletis J; Ioannou S; Iniotaki-Theodoraki A; Kostakis A
Eur J Immunogenet; 2002 Oct; 29(5):401-7. PubMed ID: 12358849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
